Prognostic parameter for high risk prostate cancer patients at initial presentation-Reference-Cited by-同舟云学术

Prognostic parameter for high risk prostate cancer patients at initial presentation

Published:2017-11-02 Issue:1 Volume:78 Page:11-16
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Kato Masashi¹^ORCID,Kimura Kyosuke²,Hirakawa Akihiro³,Kobayashi Yumiko⁴,Ishida Ryo⁵,Kamihira Osamu⁶,Majima Tsuyoshi¹,Funahashi Yasuhito¹,Sassa Naoto¹,Matsukawa Yoshihisa¹,Hattori Ryohei⁷,Gotoh Momokazu¹,Tsuzuki Toyonori⁸

Affiliation:

1. Department of Urology; Nagoya University Graduate School of Medicine; Nagoya Japan

2. Department of Urology; National Hospital Organization Nagoya Medical Center; Nagoya Japan

3. Department of Biostatistics and Bioinformatics; Graduate School of Medicine, The University of Tokyo; Tokyo Japan

4. Statistical Analysis Section; Center for Advanced Medicine and Clinical Research; Nagoya University Hospital; Nagoya Japan

5. Department of Urology; Japanese Red Cross Nagoya Daini Hospital; Nagoya Japan

6. Department of Urology; Komaki City Hospital; Komaki Japan

7. Department of Urology; Japanese Red Cross Nagoya Daiichi Hospital; Nagoya Japan

8. Department of Surgical Pathology; School of Medicine; Aichi Medical University; Nagakute Japan

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23438/fullpdf

Reference29 articles.

1. The 2014 International Society of Urological Pathology (isup) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol,2016

2. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2017

3. Intraductal carcinoma of the prostate: a comprehensive and updated review;Tsuzuki;Int J Urol,2015

4. Intraductal carcinoma of the prostate: the whole story;Zhou;Pathology,2013

5. Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories;Taylor;Nat Commun,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management;Urologic Oncology: Seminars and Original Investigations;2024-05

2. Can General Anesthesia Facilitate the Detection of Clinically Significant Prostate Cancer in Prostate Fusion Biopsy?;Andrologia;2024-01

3. Intraductal Prostatic Carcinoma: Epidemiological and Anatomopathological Aspects in Dakar;Open Journal of Pathology;2024

4. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review;European Urology;2023-07

5. Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study;Cancers;2023-04-09